Formulation development and characterization of lumefantrine nanosuspension for enhanced antimalarial activity.
Lumefantrine
Nanosuspension
Oral bioavailability
anti-malarial agent
drug delivery
solubility
Journal
Journal of biomaterials science. Polymer edition
ISSN: 1568-5624
Titre abrégé: J Biomater Sci Polym Ed
Pays: England
ID NLM: 9007393
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
pubmed:
1
1
2021
medline:
16
10
2021
entrez:
31
12
2020
Statut:
ppublish
Résumé
Variable and low oral bioavailability (4-11%) of lumefantrine (LUF), an anti-malarial agent, is characterized by very low solubility in aqueous vehicle. Thus, the present study was intended to formulate lyophilized nanosuspensions of LUF to resolve its solubility issues for the improvement of oral bioavailability. A three level 3
Identifiants
pubmed: 33380264
doi: 10.1080/09205063.2020.1870378
doi:
Substances chimiques
Antimalarials
0
Suspensions
0
Lumefantrine
F38R0JR742
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM